Interfering with critical steps of the viral replication cycle to diminish SARS-CoV-2 propagation / submitted by Kim Maren Stegmann ; 1st Referee: Prof. Dr. Matthias dobbelstein, 2nd Referee: Prof. Dr. Bernd Wollnik, Prof. Dr. Stefan Pöhlmann
The ongoing COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has so far infected more than 0.5 billion people worldwide, with at least 6.3 million deaths, and constitutes one of the largest global health crises in the recent past. The fast progression of the COVID-19 pandemic and the rapid emergence of SARS-CoV-2 variants raised urgent need for effective therapies. In order to contribute to combating the disease, we isolated SARS-CoV-2 from a local COVID-19 patient. Using this virus strain for cell culture experiments, we conducted and contributed to several projects, aiming a....
http://resolver.sub.uni-goettingen.de/purl?ediss-11858/14275$xR$3Volltext$4LF$534.
http://nbn-resolving.org/urn:nbn:de:gbv:7-ediss-14275-4$xR$3Volltext$4LF$534.
http://creativecommons.org/licenses/by/4.0/$yLinzenz.
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
Göttingen: 2022 |
| Weitere Ausgaben: |
Erscheint auch als Druck-Ausgabe: Interfering with critical steps of the viral replication cycle to diminish SARS-CoV-2 propagation |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Stegmann, Kim Maren [VerfasserIn] |
|---|---|
| Hochschulschrift: |
| Links: |
nbn-resolving.org [kostenfrei] |
|---|
| Themen: |
COVID-19 |
|---|
| Umfang: |
Illustrationen, Diagramme |
|---|
| Weitere IDs: |
urn:nbn:de:gbv:7-ediss-14275-4 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1818258641 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 1818258641 | ||
| 003 | DE-627 | ||
| 005 | 20240116092803.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221009s2022 gw |||||om 00| ||eng c | ||
| 024 | 7 | |a urn:nbn:de:gbv:7-ediss-14275-4 |2 urn | |
| 035 | |a (DE-627)1818258641 | ||
| 035 | |a (DE-599)KXP1818258641 | ||
| 035 | |a (OCoLC)1347052559 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-DE-NI | ||
| 082 | 0 | |a 610 |2 22 | |
| 082 | 0 | 4 | |a 616.9 |q DE-101 |
| 082 | 0 | 4 | |a 610 |q DE-101 |
| 100 | 1 | |a Stegmann, Kim Maren |e verfasserin |0 (DE-588)1316060195 |0 (DE-627)1878146580 |4 aut | |
| 245 | 1 | 0 | |a Interfering with critical steps of the viral replication cycle to diminish SARS-CoV-2 propagation |c submitted by Kim Maren Stegmann ; 1st Referee: Prof. Dr. Matthias dobbelstein, 2nd Referee: Prof. Dr. Bernd Wollnik, Prof. Dr. Stefan Pöhlmann |
| 264 | 1 | |a Göttingen |c 2022 | |
| 300 | |b Illustrationen, Diagramme | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 502 | |b Dissertation |c Georg-August-Universität Göttingen | ||
| 520 | |a The ongoing COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has so far infected more than 0.5 billion people worldwide, with at least 6.3 million deaths, and constitutes one of the largest global health crises in the recent past. The fast progression of the COVID-19 pandemic and the rapid emergence of SARS-CoV-2 variants raised urgent need for effective therapies. In order to contribute to combating the disease, we isolated SARS-CoV-2 from a local COVID-19 patient. Using this virus strain for cell culture experiments, we conducted and contributed to several projects, aiming a... | ||
| 520 | |a http://resolver.sub.uni-goettingen.de/purl?ediss-11858/14275$xR$3Volltext$4LF$534 | ||
| 520 | |a http://nbn-resolving.org/urn:nbn:de:gbv:7-ediss-14275-4$xR$3Volltext$4LF$534 | ||
| 520 | |a http://creativecommons.org/licenses/by/4.0/$yLinzenz | ||
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Nanobody | |
| 650 | 4 | |a Main protease | |
| 650 | 4 | |a Methotrexate | |
| 650 | 4 | |a Remdesivir | |
| 650 | 4 | |a DHODH | |
| 650 | 4 | |a Molnupiravir | |
| 650 | 4 | |a N4-hydroxycytidine | |
| 650 | 4 | |a RNA replication | |
| 650 | 4 | |a Nucleotide synthesis | |
| 650 | 4 | |a Nucleoside analogues | |
| 655 | 7 | |a Hochschulschrift |0 (DE-588)4113937-9 |0 (DE-627)105825778 |0 (DE-576)209480580 |2 gnd-content | |
| 700 | 1 | |a Dobbelstein, Matthias |e akademischer betreuerin |4 dgs | |
| 700 | 1 | |a Dobbelstein, Matthias |e akademischer betreuerin |4 dgs | |
| 700 | 1 | |a Wollnik, Bernd |e akademischer betreuerin |4 dgs | |
| 700 | 1 | |a Pöhlmann, Stefan |e akademischer betreuerin |4 dgs | |
| 751 | |a Göttingen |0 (DE-588)4021477-1 |0 (DE-627)106313819 |0 (DE-576)20893815X |4 uvp | ||
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Stegmann, Kim Maren |t Interfering with critical steps of the viral replication cycle to diminish SARS-CoV-2 propagation |d Göttingen, 2022 |h X, 278, XXXIV Seiten |w (DE-627)181825865X |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:gbv:7-ediss-14275-4 |x Resolving-System |z kostenfrei |
| 856 | 4 | 0 | |u https://d-nb.info/1298434866/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |
| 912 | |a GBV-ODiss | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a ISIL_DE-84 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_21 | ||
| 912 | |a ISIL_DE-46 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a ISIL_DE-7 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a ISIL_DE-705 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a ISIL_DE-841 | ||
| 912 | |a GBV_ILN_132 | ||
| 912 | |a ISIL_DE-959 | ||
| 912 | |a GBV_ILN_213 | ||
| 912 | |a ISIL_DE-551 | ||
| 912 | |a GBV_ILN_230 | ||
| 912 | |a ISIL_DE-552 | ||
| 912 | |a GBV_ILN_2403 | ||
| 912 | |a ISIL_DE-LFER | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 610 | ||
| 980 | |2 20 |1 01 |x 0084 |b 4376341622 |y x |z 15-09-23 | ||
| 980 | |2 21 |1 01 |x 0046 |b 4376382418 |y z |z 15-09-23 | ||
| 980 | |2 22 |1 01 |x 0018 |b 4376448214 |h SUBolrd |y xu |z 15-09-23 | ||
| 980 | |2 40 |1 01 |x 0007 |b 4195376149 |h ediss |y asn |z 09-10-22 | ||
| 980 | |2 60 |1 01 |x 0705 |b 4376530190 |h OLRD |y z |z 15-09-23 | ||
| 980 | |2 105 |1 01 |x 0841 |b 4376686379 |y z |z 15-09-23 | ||
| 980 | |2 132 |1 01 |x 0959 |b 4376605654 |h OLR-DISS |y x |z 15-09-23 | ||
| 980 | |2 213 |1 01 |x 0551 |b 4376645370 |h ORD |y x |z 15-09-23 | ||
| 980 | |2 230 |1 01 |x 0552 |b 4376661295 |h ORD |y x |z 15-09-23 | ||
| 980 | |2 2403 |1 01 |x DE-LFER |b 4374285342 |c 00 |f --%%-- |d --%%-- |e n |j --%%-- |y l01 |z 11-09-23 | ||
| 981 | |2 20 |1 01 |x 0084 |r https://nbn-resolving.de/urn:nbn:de:gbv:7-ediss-14275-4 | ||
| 981 | |2 21 |1 01 |x 0046 |r https://nbn-resolving.de/urn:nbn:de:gbv:7-ediss-14275-4 | ||
| 981 | |2 22 |1 01 |x 0018 |r https://nbn-resolving.de/urn:nbn:de:gbv:7-ediss-14275-4 | ||
| 981 | |2 40 |1 01 |x 0007 |r http://resolver.sub.uni-goettingen.de/purl?ediss-11858/14275 |z LF |3 Volltext | ||
| 981 | |2 60 |1 01 |x 0705 |r https://nbn-resolving.de/urn:nbn:de:gbv:7-ediss-14275-4 | ||
| 981 | |2 105 |1 01 |x 0841 |r https://nbn-resolving.de/urn:nbn:de:gbv:7-ediss-14275-4 | ||
| 981 | |2 132 |1 01 |x 0959 |r https://nbn-resolving.de/urn:nbn:de:gbv:7-ediss-14275-4 | ||
| 981 | |2 213 |1 01 |x 0551 |r https://nbn-resolving.de/urn:nbn:de:gbv:7-ediss-14275-4 | ||
| 981 | |2 230 |1 01 |x 0552 |r https://nbn-resolving.de/urn:nbn:de:gbv:7-ediss-14275-4 | ||
| 981 | |2 2403 |1 01 |x DE-LFER |r https://nbn-resolving.org/urn:nbn:de:gbv:7-ediss-14275-4 | ||
| 983 | |2 40 |1 00 |x DE-7 |8 00 |0 (DE-627)619875399 |a MED 334 |b Infektionskrankheiten | ||
| 983 | |2 60 |1 01 |x 0705 |8 10 |a ho | ||
| 985 | |2 20 |1 01 |x 0084 |a OLRD | ||
| 995 | |2 22 |1 01 |x 0018 |a SUBolrd | ||
| 995 | |2 40 |1 01 |x 0007 |a ediss | ||
| 995 | |2 60 |1 01 |x 0705 |a OLRD | ||
| 995 | |2 132 |1 01 |x 0959 |a OLR-DISS | ||
| 995 | |2 213 |1 01 |x 0551 |a ORD | ||
| 995 | |2 230 |1 01 |x 0552 |a ORD | ||